Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy (VANISH)

This study has been completed.
St. Jude Medical
Biosense Webster, Inc.
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
John Sapp, Nova Scotia Health Authority Identifier:
First received: May 20, 2009
Last updated: July 8, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):